Quantification of pulmonary blood flow (PBF): Validation of perfusion MRI and nonlinear contrast agent (CA) dose correction with HO positron emission tomography (PET)
Validation of quantification of pulmonary blood flow (PBF) with dynamic, contrast‐enhanced MRI is still missing. A possible reason certainly lies in difficulties based on the nonlinear dependence of signal intensity (SI) from contrast agent (CA) concentration. Both aspects were addressed in this stu...
Gespeichert in:
Veröffentlicht in: | Magnetic resonance in medicine 2009-08, Vol.62 (2), p.476-487 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Validation of quantification of pulmonary blood flow (PBF) with dynamic, contrast‐enhanced MRI is still missing. A possible reason certainly lies in difficulties based on the nonlinear dependence of signal intensity (SI) from contrast agent (CA) concentration. Both aspects were addressed in this study. Nine healthy pigs were examined by first‐pass perfusion MRI using gadolinium diethylenetriamine pentaacetic acid (Gd‐DTPA) and H
O positron emission tomography (PET) imaging. Calculations of hemodynamic parameters were based on a one‐compartment model (MR) and a two‐compartment model (PET). Simulations showed a significant error when assuming a linear relation between MR SI and CA dose in the arterial input function (AIF), even at low doses of 0.025 mmol/kg body weight (BW). To correct for nonlinearity, a calibration curve was calculated on the basis of the signal equation. The required accuracy of equation parameters (like longitudinal relaxation time) was evaluated. Error analysis estimates |
---|---|
ISSN: | 0740-3194 1522-2594 |
DOI: | 10.1002/mrm.22025 |